Research
On-device research index

arXiv research

A locally-built, LLM-digested index of recent arXiv papers in quant finance, geometry/topology, and statistical ML — keyword search served straight from SQLite on this machine.

169,181 papers · 148 categories

Trend · papers per month

0.3%0.5%0.8%0.5% · Jul 200919922001200920182026
48 results for ligand docking

Deep learning model predicts protein-ligand binding modes from docking data.

problem Improving protein-ligand binding mode prediction accuracy.
method Dual-graph architecture with separate sub-networks for ligand topology and protein-ligand interactions.
result Deep learning model outperforms docking programs in binding mode prediction.

DOCKSTRING simplifies docking simulations for better drug design benchmarks.

problem Lack of meaningful benchmarks for ligand design.
method Open-source Python package for docking scores, extensive dataset, and pharmaceutically-relevant tasks.
result Docking scores are more appropriate benchmarks than simple physicochemical properties.

Novel GNN predicts drug-target interactions using protein-ligand 3D structures.

problem Accurate prediction of drug-target interactions for in silico drug design.
method 3D structure-embedded graph representations and distance-aware graph attention algorithm with gate augmentation.
result Our model outperforms docking and other deep learning methods in virtual screening and pose prediction.

New model uses pretrained biochemical language models to generate drug compounds.

problem Developing novel compounds targeting specific proteins.
method Exploits pretrained language models to initialize and fine-tune targeted molecule generation models.
result Warm-started models outperform baseline models, with one-stage strategy showing better generalization.

Bayesian Active Learning improves protein docking accuracy and uncertainty quantification.

problem Uncertainty quantification in protein docking optimization.
method Bayesian Active Learning (BAL) for optimization and uncertainty quantification of protein docking.
result BAL significantly improves docking accuracy and provides tight confidence intervals.

3DGCN predicts molecular properties and biochemical activities using 3D molecular graph.

problem Predicting molecular properties and biochemical activities from 3D molecular graphs.
method Unified graph convolution with learning operations to handle spatial information, distinguishing 3D rotations.
result Significantly higher performance on various molecular tasks compared to other deep-learning models.

Unified model learns from proteins and ligands for drug design.

problem Disjoint data sources and modeling assumptions limit joint use of structure- and ligand-based drug design.
method Contrastive Geometric Learning for Unified Computational Drug Design (ConGLUDe)
result Unified model achieves competitive zero-shot virtual screening performance and state-of-the-art ligand-conditioned pocket selection.

ChemBoost predicts protein-ligand binding affinity using SMILES syntax.

problem Predicting high affinity drug-target interactions from sequence similarity alone.
method ChemBoost uses SMILES syntax to represent ligands as documents and proteins as sequences or ligand-centric features. It learns chemical word embeddings and predicts affinities using eXtreme Gradient Boosting.
result ChemBoost outperforms state-of-the-art systems in predicting protein-ligand affinities.

InteractionNet models noncovalent protein-ligand interactions with GNNs and explains predictions.

problem Modeling noncovalent protein-ligand interactions with graph neural networks.
method InteractionNet uses a GNN architecture with separated covalent and noncovalent convolution layers and layer-wise relevance propagation for explainability.
result InteractionNet successfully predicts noncovalent protein-ligand interactions with chemical relevance.

Deep learning predicts protein-ligand binding affinity with high accuracy.

problem Predicting protein-ligand binding affinity for drug discovery.
method 3D convolutional neural network trained on CASF and Astex Diverse Set benchmarks.
result Deep learning model outperformed classical scoring functions.

Computational approaches to drug discovery can reduce the time and cost associated with experimental assays and enable the screening of novel chemotypes. Structure-based drug design methods rely on scoring functions to rank and predict binding affinities and poses. The ever-expanding amount of protein-ligand binding an…

2016-12-08abs ↗pdf ↗

SDG uses optimal control to improve classifier guidance in low-density regions.

problem Inefficient guidance in low-density regions of posterior distributions.
method Integrates stochastic optimal control with Stein variational inference to compute the steepest descent direction.
result SDG improves guidance in low-density regions, outperforming standard methods.

NeuralMD accelerates protein-ligand binding simulations 1Kx faster.

problem Accurate and efficient simulation of protein-ligand binding dynamics.
method Physics-informed multi-grained group symmetric framework with BindingNet and augmented neural differential equation solver.
result Achieves over 1Kx speedup and up to 15x reduction in reconstruction error compared to standard methods.

ALCNN predicts bike demand patterns in new cities using multi-source geographic data.

problem Inferring fine-grained bike demands in new cities with limited data.
method Extract features from POI, road networks, and nighttime light; use coPCA for adaptation; apply DWT for daily patterns; use attention-based local CNN (ALCNN).
result ALCNN outperforms other methods in predicting bike demand patterns.

Novel parallel GNN predicts protein-ligand interactions with high accuracy.

problem Accurate prediction of protein-ligand interactions for drug design.
method Parallel Graph Neural Networks (GNN) integrating 3D structural data.
result GNN achieves high accuracy in predicting binary interactions and activity.

WideDTA predicts drug-target binding affinity using text-based information.

problem Predicting drug-target binding affinity is a major challenge in drug discovery.
method WideDTA uses chemical and biological textual sequence information, including protein sequence, ligand SMILES, protein domains and motifs, and maximum common substructure words.
result WideDTA outperformed DeepDTA on the KIBA dataset, indicating the word-based sequence representation is a promising alternative.

According to Cobanoglu et al and Murphy, it is now widely acknowledged that the single target paradigm (one protein or target, one disease, one drug) that has been the dominant premise in drug development in the recent past is untenable. More often than not, a drug-like compound (ligand) can be promiscuous - that is, i…

2014-11-23abs ↗pdf ↗

Improved 3D generative models for drug design reduce bias and enhance data efficiency.

problem Data sparsity and bias in 3D molecular design models.
method Multi-level contrastive learning protocol for bias control and data efficiency.
result Hierarchical generative models that are topologically unbiased and explainable.

This abstract reviews recent methods for predicting protein-ligand binding affinity.

problem Predicting protein-ligand binding affinity for various applications in life sciences.
method Traditional and deep learning models for binding affinity prediction.
result Improved predictive performance of AI-driven models.

Calibrated Boosting-Forest improves ranking and probability calibration in classification tasks.

problem Need for superior ranking power and well-calibrated probability estimates in classification tasks.
method Ensemble of gradient boosting machines supporting both continuous and binary labels.
result Calibrated Boosting-Forest achieves significant improvements in ranking and probability calibration compared to state-of-the-art models.

This study analyzes how weather impacts bike sharing usage in Washington D.C.

problem Understanding how weather affects bike sharing usage patterns.
method Gathered bike usage and weather data, used k-means clustering algorithm to identify clusters.
result Weather significantly impacts bike usage, with temperature and precipitation being the most influential factors.

New method models aptamer libraries as Boltzmann-weighted graph ensembles for better affinity predictions.

problem Anomalous candidates in SELEX datasets obscure true aptamer-ligand affinity.
method Boltzmann graph ensemble embeddings for thermodynamically parameterized exponential-family random graphs.
result Proposed embedding enables robust community detection and subgraph-level explanations for aptamer ligand affinity.

Dimensionality reduction helps analyze molecular simulations data.

problem High-dimensional molecular simulation data is hard to analyze.
method Various dimensionality reduction methods (k-means, autoencoder, PCA, tICA) applied to molecular simulation data.
result Methods learned different conformations of molecular processes.

Proposes CCCVAE for better single-cell clustering with cell-cell communication.

problem Improving single-cell RNA sequencing clustering by incorporating cell-cell communication.
method Integrates cell-cell communication into a variational autoencoder framework.
result Empirical results show CCCVAE outperforms standard VAEs in clustering performance.

Machine learning attacks mimic cellular decision-making, revealing new defense mechanisms.

problem Adversarial perturbations fool machine learning models, similar to how ligands prevent correct signaling in cells.
method Formal analogy between neural networks and cellular decision-making models, applying machine learning techniques to study cellular processes.
result Found two regimes in cellular decision-making models, each with a critical point that shapes the loss landscape and defense mechanisms.

DeepDTA predicts drug-target binding affinities using deep learning.

problem Predicting the continuum of binding strength values between drugs and targets.
method Uses deep learning, specifically CNNs, to model 1D representations of drug and target sequences.
result Deep learning model outperforms state-of-the-art methods in predicting DT binding affinities.

Molecular "fingerprints" encoding structural information are the workhorse of cheminformatics and machine learning in drug discovery applications. However, fingerprint representations necessarily emphasize particular aspects of the molecular structure while ignoring others, rather than allowing the model to make data-d…

2016-03-02abs ↗pdf ↗

Deep learning methods such as multitask neural networks have recently been applied to ligand-based virtual screening and other drug discovery applications. Using a set of industrial ADMET datasets, we compare neural networks to standard baseline models and analyze multitask learning effects with both random cross-valid…

2016-06-28abs ↗pdf ↗

New meta-optimizer learns from both point-based and population-based algorithms.

problem Current meta-optimizers are limited in space and unaware of uncertainty.
method Proposes a new meta-optimizer that learns in the space of both point-based and population-based algorithms, targeting a meta-loss function of cumulative regret and entropy.
result Empirical results show superior performance over existing competitors.